mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.2 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.074 |
0.2 |